molecules of the month

March 2021

The March 2021 edition of Drug Hunter‘s Small Molecules of the Month series contains several small molecule clinical candidates as well as pre-clinical small molecules with interesting structures or mechanisms. Among the highlights are LSN3318839, a molecular glue that binds both GLP-1R receptor its endogenous GLP peptide, a P-gp inhibitor intended to induce a drug-drug interaction (DDI), and two non-traditional zinc binders including a hydantoin and a phosphinic acid. There are numerous chemistry rule-breakers here, including an oral brain penetrant compound with 5 rings, a compound with a predicted human oral dose of 15 mg with 6 hydrogen bond donors (HBDs) and 6 rings, and a venetoclax prodrug that enables a 100 mg pill.

A slide deck with more details about each molecule is available.

Upgrade Membership to Download Slide Deck

nominate a molecule

Encountered an interesting new molecule? Let your community know!

become a reviewer

Get sneak previews of upcoming molecules and share your knowledge and expertise with the drug discovery community.

past molecules of the month

Check out previous selections below.

molecules of the year nominees

Previous selections for Drug Hunter’s Molecule of the Year below.

hall of fame
molecules of the year

Previous selections for Drug Hunter’s Molecule of the Year below.

ask your company about a Drug Hunter membership

Member Benefits

  • Stay up-to-date and save more time with exclusive members-only content
  • On-board new team members with educational content and case studies
  • Generate ideas and discussion with easy-to-read slide decks
  • Support new content and build your industry community